Components in tobacco smoke and electronic cigarette form adducts with DNA.

Air 2, LLC

Components in tobacco smoke and electronic cigarette (e-cigarette) aerosol form adducts with DNA, which can cause DNA mutations and affect repair of DNA damage. 

DNA adducts are significant biomarkers of tobacco exposure
Numerous studies have shown a strong association between inhaled smoke and lung cancer. The presence of DNA adducts can indicate chemical components of smoke. Therefore, DNA adducts are significant biomarkers of tobacco exposure that might predict lung disease status and serve as precursors to lung cancer, since they trigger DNA mutations and impair biological processes such as DNA replication and transcription.


In 2019, the United States experienced an outbreak of lung injuries
In recent years, e-cigarettes have been popular among young people because of their unique flavor and they are considered a substitute for conventional cigarettes. However, e-cigarettes are not harmless. In 2019, the United States experienced an outbreak of lung injuries associated with the use of e-cigarettes and e-cigarette products, thus resulting in 2800 hospitalizations, and highlighting the dangers of e-cigarettes and products.


Chemical carcinogens in conventional cigarettes and e-cigarettes

Conventional cigarette smoke and e-cigarette aerosol contain different types and concentrations of chemical carcinogens. Many chemical carcinogens in conventional cigarettes and e-cigarettes are reactive and challenging to measure directly.

Biological Consequence
The formation of DNA adducts is a crucial initial event in the induction of mutations and triggering of cancer development through chemical carcinogens, thus linking chemical carcinogens to cancer occurrence at the molecular level. The biological effects of DNA adducts include impeding DNA replication, inducing mutations that can lead to cancer, and being closely associated with aging


VIEW ENTIRE ARTICLE


By Air 2, LLC November 19, 2025
Is Altria ON!, or OFF? While on! held an 8.7% share of the total U.S. oral tobacco category, its position within the nicotine pouch segment slipped to 15.6%, down 4.1 points amid highly elevated competitor promotional activity.
By Air 2, LLC October 30, 2025
The tobacco industry is evolving amid declining cigarette consumption, tighter regulations and growing demand for cleaner nicotine delivery systems.
By Air 2, LLC October 16, 2025
In 2025, 17 U.S. Ballpark's have committed to TOBACCO FREE stadiums. Proposal looks to ban chewing tobacco, ZYN at pro stadiums.
By Air 2, LLC October 6, 2025
WHO estimates at least 15 million teenagers use e-cigarettes worldwide. Nicotine reduction? We don't think so.
By Air 2, LLC September 8, 2025
Exclusive: US FDA to fast-track nicotine pouch reviews amid White House pressure.
By Air 2, LLC August 19, 2025
How BAT’s tobacco-free oral nicotine strategy is reshaping the public health conversation in the Middle East.
By Air2, LLC August 6, 2025
Federal Judge Rules FDA Tobacco Penalties Unconstitutional Without Jury Trial.
By Air 2, LLC July 22, 2025
A cross between a nicotine pouch and an energy drink: What to know about caffeine pouches.
By Air 2, LLC July 8, 2025
The race is on for success in harm reduction: encouraging smokers to switch completely to reduced risk alternatives. Evidence of this rapidly evolving trend can be seen from all lanes — consumers, manufacturers, retailers, the government and even public health.
BAT AIR2 VAPOR
By Air 2, LLC June 23, 2025
Globally, public health strategies have focused on tobacco control measures to make smoking less appealing. While tobacco control has a role to play, it is only part of the solution.
More Posts